213 related articles for article (PubMed ID: 25038231)
1. HSV-sr39TK positron emission tomography and suicide gene elimination of human hematopoietic stem cells and their progeny in humanized mice.
Gschweng EH; McCracken MN; Kaufman ML; Ho M; Hollis RP; Wang X; Saini N; Koya RC; Chodon T; Ribas A; Witte ON; Kohn DB
Cancer Res; 2014 Sep; 74(18):5173-83. PubMed ID: 25038231
[TBL] [Abstract][Full Text] [Related]
2. IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune System.
Puig-Saus C; Parisi G; Garcia-Diaz A; Krystofinski PE; Sandoval S; Zhang R; Champhekar AS; McCabe J; Cheung-Lau GC; Truong NA; Vega-Crespo A; Komenan MDS; Pang J; Macabali MH; Saco JD; Goodwin JL; Bolon B; Seet CS; Montel-Hagen A; Crooks GM; Hollis RP; Campo-Fernandez B; Bischof D; Cornetta K; Gschweng EH; Adelson C; Nguyen A; Yang L; Witte ON; Baltimore D; Comin-Anduix B; Kohn DB; Wang X; Cabrera P; Kaplan-Lefko PJ; Berent-Maoz B; Ribas A
Clin Cancer Res; 2019 Feb; 25(3):1000-1011. PubMed ID: 30409823
[TBL] [Abstract][Full Text] [Related]
3. A Cetuximab-Mediated Suicide System in Chimeric Antigen Receptor-Modified Hematopoietic Stem Cells for Cancer Therapy.
Kao RL; Truscott LC; Chiou TT; Tsai W; Wu AM; De Oliveira SN
Hum Gene Ther; 2019 Apr; 30(4):413-428. PubMed ID: 30860401
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic stem cells for cancer immunotherapy.
Gschweng E; De Oliveira S; Kohn DB
Immunol Rev; 2014 Jan; 257(1):237-49. PubMed ID: 24329801
[TBL] [Abstract][Full Text] [Related]
5. Long-term safety and activity of NY-ESO-1 SPEAR T cells after autologous stem cell transplant for myeloma.
Stadtmauer EA; Faitg TH; Lowther DE; Badros AZ; Chagin K; Dengel K; Iyengar M; Melchiori L; Navenot JM; Norry E; Trivedi T; Wang R; Binder GK; Amado R; Rapoport AP
Blood Adv; 2019 Jul; 3(13):2022-2034. PubMed ID: 31289029
[TBL] [Abstract][Full Text] [Related]
6. A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response.
Robbins PF; Kassim SH; Tran TL; Crystal JS; Morgan RA; Feldman SA; Yang JC; Dudley ME; Wunderlich JR; Sherry RM; Kammula US; Hughes MS; Restifo NP; Raffeld M; Lee CC; Li YF; El-Gamil M; Rosenberg SA
Clin Cancer Res; 2015 Mar; 21(5):1019-27. PubMed ID: 25538264
[TBL] [Abstract][Full Text] [Related]
7. Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell lines.
Zhao Y; Zheng Z; Robbins PF; Khong HT; Rosenberg SA; Morgan RA
J Immunol; 2005 Apr; 174(7):4415-23. PubMed ID: 15778407
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive detection of tumor-infiltrating T cells by PET reporter imaging.
McCracken MN; Vatakis DN; Dixit D; McLaughlin J; Zack JA; Witte ON
J Clin Invest; 2015 May; 125(5):1815-26. PubMed ID: 25822024
[TBL] [Abstract][Full Text] [Related]
9. Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression.
Poncette L; Chen X; Lorenz FK; Blankenstein T
J Clin Invest; 2019 Jan; 129(1):324-335. PubMed ID: 30530988
[TBL] [Abstract][Full Text] [Related]
10. Allelic exclusion and peripheral reconstitution by TCR transgenic T cells arising from transduced human hematopoietic stem/progenitor cells.
Giannoni F; Hardee CL; Wherley J; Gschweng E; Senadheera S; Kaufman ML; Chan R; Bahner I; Gersuk V; Wang X; Gjertson D; Baltimore D; Witte ON; Economou JS; Ribas A; Kohn DB
Mol Ther; 2013 May; 21(5):1044-54. PubMed ID: 23380815
[TBL] [Abstract][Full Text] [Related]
11. [(18)F]FHBG PET/CT Imaging of CD34-TK75 Transduced Donor T Cells in Relapsed Allogeneic Stem Cell Transplant Patients: Safety and Feasibility.
Eissenberg LG; Rettig MP; Ritchey JK; Prior JL; Schwarz SW; Frye J; White BS; Fulton RS; Ghobadi A; Cooper ML; Couriel DR; Seegulam ME; Piwnica-Worms D; Dehdashti F; Cornetta K; DiPersio JF
Mol Ther; 2015 Jun; 23(6):1110-1122. PubMed ID: 25807290
[TBL] [Abstract][Full Text] [Related]
12. Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via Notch signaling.
Zhao Y; Parkhurst MR; Zheng Z; Cohen CJ; Riley JP; Gattinoni L; Restifo NP; Rosenberg SA; Morgan RA
Cancer Res; 2007 Mar; 67(6):2425-9. PubMed ID: 17363559
[TBL] [Abstract][Full Text] [Related]
13. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
[TBL] [Abstract][Full Text] [Related]
14. Pre-clinical development of gene modification of haematopoietic stem cells with chimeric antigen receptors for cancer immunotherapy.
Larson SM; Truscott LC; Chiou TT; Patel A; Kao R; Tu A; Tyagi T; Lu X; Elashoff D; De Oliveira SN
Hum Vaccin Immunother; 2017 May; 13(5):1094-1104. PubMed ID: 28059624
[TBL] [Abstract][Full Text] [Related]
15. Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma.
Schuberth PC; Jakka G; Jensen SM; Wadle A; Gautschi F; Haley D; Haile S; Mischo A; Held G; Thiel M; Tinguely M; Bifulco CB; Fox BA; Renner C; Petrausch U
Gene Ther; 2013 Apr; 20(4):386-95. PubMed ID: 22739387
[TBL] [Abstract][Full Text] [Related]
16. Generation of Genetically Engineered Precursor T-Cells From Human Umbilical Cord Blood Using an Optimized Alpharetroviral Vector Platform.
Hübner J; Hoseini SS; Suerth JD; Hoffmann D; Maluski M; Herbst J; Maul H; Ghosh A; Eiz-Vesper B; Yuan Q; Ott M; Heuser M; Schambach A; Sauer MG
Mol Ther; 2016 Aug; 24(7):1216-26. PubMed ID: 27138041
[TBL] [Abstract][Full Text] [Related]
17. PET Reporter Gene Imaging and Ganciclovir-Mediated Ablation of Chimeric Antigen Receptor T Cells in Solid Tumors.
Murty S; Labanieh L; Murty T; Gowrishankar G; Haywood T; Alam IS; Beinat C; Robinson E; Aalipour A; Klysz DD; Cochran JR; Majzner RG; Mackall CL; Gambhir SS
Cancer Res; 2020 Nov; 80(21):4731-4740. PubMed ID: 32958548
[TBL] [Abstract][Full Text] [Related]
18. Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy.
Mercier-Letondal P; Marton C; Deschamps M; Ferrand C; Vauchy C; Chenut C; Baguet A; Adotévi O; Borg C; Galaine J; Godet Y
Hum Gene Ther; 2018 Oct; 29(10):1202-1212. PubMed ID: 30136612
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic modulation to enable antigen-specific T-cell therapy of colorectal cancer.
Chou J; Voong LN; Mortales CL; Towlerton AM; Pollack SM; Chen X; Yee C; Robbins PF; Warren EH
J Immunother; 2012; 35(2):131-41. PubMed ID: 22306901
[TBL] [Abstract][Full Text] [Related]
20. Lentiviral vector conferring resistance to mycophenolate mofetil and sensitivity to ganciclovir for in vivo T-cell selection.
Sangiolo D; Lesnikova M; Nash RA; Jensen MC; Nikitine A; Kiem HP; Georges GE
Gene Ther; 2007 Nov; 14(21):1549-54. PubMed ID: 17805303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
